Skip to content

Clinical trials

Phase 1 Obesity trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Obesity Phase: Phase 1 Country / region: United Kingdom Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20084
20093
20104
20122
20141
20152
20161
20171
20221
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Recruiting2
Terminated2
Unknown status2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca7
GlaxoSmithKline7
Imperial College London5
Novo Nordisk A/S2
Aberystwyth University1
Boehringer Ingelheim1
Gedeon Richter Plc.1
Stefan Soderberg1
Vernalis (R&D) Ltd1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Obesity26
Overweight6
Diabetes Mellitus3
Diabetes Mellitus, Type 22
Alcoholism1
Aneurysm1
Arthritis, Rheumatoid1
Food Addiction1
Nutrition Disorders1
Substance-Related Disorders1

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.